Nervmyo
1 known investors
NervMyo Therapeutics develops a long-acting injectable delivery system combining a FDA-approved biologic (IGF-1) to improve nerve regrowth and prevent muscle wasting following peripheral nerve injury. The company targets nerve injury patients requiring regenerative therapeutics.
Founders & leadership
E
EricaCEO + Co-Founder
S
SamiCo-Founder
Investors · 1
Frequently asked questions
- What does Nervmyo do?
- NervMyo Therapeutics develops a long-acting injectable delivery system combining a FDA-approved biologic (IGF-1) to improve nerve regrowth and prevent muscle wasting following peripheral nerve injury. The company targets nerve injury patients requiring regenerative therapeutics.
- Who founded Nervmyo?
- Nervmyo was founded by Erica, Sami.
- Who are Nervmyo's investors?
- Nervmyo's investors include The Innovation Space.